(*) EU Conditional OK: 2020. 07.03
(*) JP Approval Date: 2020. 05.07
(*) USA Approval Date: 2020. 10.22
>RdRp Inhibitor for Injection
Company
Generic Name: Remdesivir
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 4
Patent>UpDate: 2021. 12.28
RdRp: RNA-dependent RNA polymerase
RTM
RTM Web-Site